Northwestern University: Breast Neoplasms trials

The registry lists 60 Breast Neoplasms studies with Northwestern University as lead sponsor. 4 are open to participants now and 16 have results posted.

Early Phase 1 3Phase 1 11Phase 2 23Phase 3 2No phase 23(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Fit2ThriveMB: Optimization of a Physical Activity Promotion Intervention for Metastatic Breast Cancer PatientsNot yet recruitingNCT07840599Not applicable
• Evaluating the Impact of Financial Navigation on Financial Catastrophe and Distress for Cancer CareRecruitingNCT06630962Not applicable
• Elacestrant vs Elacestrant Plus a CDK4/6 Inhibitor in Patients With ERpositive/HER2-negative Advanced or Metastatic Breast CancerRecruitingNCT06062498Phase 2
• Collecting Tissue Samples for Future Research From Women Undergoing Surgery for Breast CancerRecruitingNCT00898131
• Technology-Supported Physical Activity Intervention for Metastatic Breast Cancer Survivors: Fit2ThriveMBCompletedNCT04129346Not applicableResults posted
• Pembrolizumab and Carboplatin in Treating Patients With Circulating Tumor Cells Positive Metastatic Breast CancerCompletedNCT03213041Phase 2Results posted
• Optimization of Remotely Delivered Physical Activity Intervention for Breast Cancer SurvivorsCompletedNCT03131440Not applicableResults posted
• Denosumab in Treating Patients With ER and/or PR Positive, HER2 Negative Metastatic Breast Cancer With Bone Metastases and Detectable Circulating Tumor CellsTerminatedNCT03070002Phase 2Results posted
• Pembrolizumab and Capecitabine in Treating Patients With Locally Advanced or Metastatic Triple Negative or Hormone-Refractory Breast Cancer That Cannot Be Removed by SurgeryStatus unknownNCT03044730Phase 2Results posted
• Testing an Active Form of Tamoxifen (4-hydroxytamoxifen) Delivered Through Breast Skin to Control Ductal Carcinoma in Situ (DCIS) of the BreastCompletedNCT02993159Phase 2Results posted
• Ipilimumab and Nivolumab in Treating Patients With Recurrent Stage IV HER2 Negative Inflammatory Breast CancerTerminatedNCT02892734Phase 2Results posted
• Palbociclib in Treating Patients With Metastatic HER-2 Positive Breast Cancer With Brain MetastasisTerminatedNCT02774681Phase 2Results posted
• MEDI4736 and Tremelimumab in Treating Patients With Metastatic HER2 Negative Breast CancerCompletedNCT02536794Phase 2Results posted
• Transdermal or Oral Telapristone Acetate in Treating Patients Undergoing MastectomyCompletedNCT02314156Phase 2Results posted
• BYL719 + T-DM1 in HER2(+) Metastatic Breast Cancer Pts Who Progress on Prior Trastuzumab & Taxane TxCompletedNCT02038010Phase 1Results posted
• Cabergoline in Metastatic Breast CancerCompletedNCT01730729Early Phase 1Results posted
• Intrathecal Trastuzumab for Leptomeningeal Metastases in HER2+ Breast CancerCompletedNCT01325207Phase 1/2Results posted
• 4-Hydroxytamoxifen or Tamoxifen Citrate in Treating Women With Newly Diagnosed Ductal Breast Carcinoma in SituCompletedNCT00952731Phase 2Results posted
• Abraxane and Lapatinib in Treating Patients With Stage I, Stage II, or Stage III Breast CancerCompletedNCT00331630Early Phase 1Results posted
• D-cycloserine in the Management of Chemotherapy-Induced Peripheral Neuropathic PainTerminatedNCT00301080Phase 3Results posted
• Breast Cancer - Navigate - Prospective CohortCompletedNCT06271356Not applicable
• Trotabresib in Combination With Vinorelbine and Radiation Therapy for the Treatment of HER2+ Breast Cancer With Central Nervous System or Leptomeningeal MetastasisWithdrawnNCT06137651Phase 1
• Breast Cancer Pre-habilitation and Prospective Surveillance to Prevent, Detect, and Optimize Physical and FunctionCompletedNCT06081127Not applicable
• Optimizing a mHealth Physical Activity Intervention With Mindful Awareness Lessons in Breast Cancer SurvivorsActive, not recruitingNCT05931874Not applicable
• Web-based Pain Coping Skills Training for Breast Cancer Survivors With AI-Associated ArthralgiaActive, not recruitingNCT05703178Phase 3
• SGT-53, Carboplatin, and Pembrolizumab for the Treatment of Metastatic Triple Negative Inflammatory Breast CancerWithdrawnNCT05093387Phase 1
• A Research Study for Latina Women With Breast CancerCompletedNCT04861896Not applicable
• Optimizing Quality of Life in Women Living With Metastatic Breast CancerCompletedNCT04374825Not applicable
• Plan to Thrive: Extending Cancer Survivorship Care Beyond the ClinicCompletedNCT03996031
• A Web-Based Tool to Improve Breast Cancer SurvivorshipCompletedNCT03849573Not applicable
• Treating Verbal Memory Deficits Following Chemotherapy for Breast CancerCompletedNCT03017560Not applicable
• The PROMISE Study: Duavee in Women With DCISCompletedNCT02694809Phase 2
• Mild Cognitive Impairment in Breast Cancer PatientsCompletedNCT01949376
• Improving Psychosocial Quality of Life in Women With Advanced Breast CancerCompletedNCT01811264Not applicable
• Oral CDB-4124 vs. Placebo in Stage I-II Primary Breast CancerStatus unknownNCT01800422Phase 2
• Test Uniformity of Transdermal Drug Delivery to Breast Using Diclofenac EpolamineCompletedNCT01380353Early Phase 1
• Carboplatin and Eribulin Mesylate in Triple Negative Breast Cancer PatientsStatus unknownNCT01372579Phase 2
• 4R for Guideline Indicated BRCA Testing of Breast Center PatientsCompletedNCT01320540
• Cryotherapy in Preventing Peripheral Neuropathy and Nail Toxicity in Patients With Breast Cancer Who Are Receiving PaclitaxelTerminatedNCT01243541Not applicable
• Low Level Laser Therapy for Hair Preservation With Chemotherapy for Breast CancerWithdrawnNCT01081106Not applicable
• Pazopanib + Vinorelbine in Non Small Cell Lung Cancer (NSCLC) and Breast CancerTerminatedNCT01060514Phase 1
• Cyclosporine A in Combination With Nab-Paclitaxel in Patients With Metastatic Breast CancerCompletedNCT00983424Phase 1
• Study of Breast Tissue in Women Not Previously Diagnosed With Breast Cancer Who Are Undergoing Fine Needle AspirationStatus unknownNCT00896636
• Phase 2b Study of Taxol Plus Sorafenib or Placebo in Patients With Advanced Breast CancerStatus unknownNCT00499525Phase 2
• Lapatinib and Doxorubicin Hydrochloride Liposome in Treating Patients With Metastatic Breast CancerCompletedNCT00316875Phase 1
• Improving Communication With Patients With Breast CancerTerminatedNCT00276822Not applicable
• High-Dose Esterified Estrogens in Treating Postmenopausal Women With Metastatic Breast Cancer That Has Failed Previous Hormone TherapyTerminatedNCT00131924Phase 2
• Effect of Tamoxifen on Breast Density in Premenopausal Women With Breast Cancer or High Risk for Breast CancerCompletedNCT00086749
• Ductal Lavage in Assessing Women With Early Breast Cancer or at High Risk of Developing Breast Cancer and Who Are Eligible For Tamoxifen TherapyWithdrawnNCT00083044
• Trastuzumab and Exemestane in Treating Postmenopausal Women With Metastatic or Locally Advanced Breast CancerWithdrawnNCT00057993Phase 2
• PS-341 in Treating Women With Metastatic Breast CancerCompletedNCT00028639Phase 2
• Peripheral Stem Cell Transplantation in Treating Patients With Breast Cancer or Hematologic CancerCompletedNCT00006225Phase 1/2
• Peripheral Stem Cell Transplantation in Treating Patients With Melanoma or Small Cell Lung, Breast, Testicular, or Kidney Cancer That is Metastatic or That Cannot Be Treated With SurgeryWithdrawnNCT00006126Phase 1
• Fluorouracil-Uracil and Leucovorin in Treating Women With Metastatic Breast CancerTerminatedNCT00005608Phase 2
• Tamoxifen to Prevent Bone Loss and Heart Disease in Premenopausal Women Receiving Chemotherapy for Stage I or Stage II Breast CancerCompletedNCT00005605
• Irinotecan in Treating Patients With Metastatic or Recurrent Breast CancerCompletedNCT00004182Phase 2
• Docetaxel, Doxorubicin, and Cyclophosphamide in Treating Women With Stage III Breast CancerCompletedNCT00004175Phase 2
• Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation in Treating Patients With Advanced Breast CancerCompletedNCT00004174Phase 1
• Chemotherapy, Filgrastim, and Stem Cell Transplantation With Radiation Therapy in Treating Patients With Stage III or Stage IV Breast CancerCompletedNCT00004172Phase 2
• Irinotecan Plus Gemcitabine in Treating Patients With Unresectable or Metastatic Solid TumorsCompletedNCT00004095Phase 1